April 18, 2011 12:04 ET
CannaBANK Transfers Third Asset to Medical Marijuana Inc. SkinAgain Joint Venture
SAN DIEGO, CA--(Marketwire - Apr 18, 2011) - Medical Marijuana Inc. (
Recognizing the potential healthcare benefits of cannabinoids, the United States government successfully filed a patent for CBDs as antioxidants and neuroprotectants that was granted on October 7, 2003 (see http://tinyurl.com/6hwwmt). Cannabidiol, the most specific non-psycho active, beneficial compound had originally been listed in the Federal Register (7372) as a Schedule 1 drug or substance but was notably absent from the list in a Code of Federal Regulations change since April 1, 2010. Some of the benefits stated in the government's patent brief included cannabinoids having antioxidant properties and being useful in treating autoimmune disorders, stroke, Alzheimer's disease, Parkinson's disease and HIV.
CannaBANK™ and SkinAgain® researchers, while undergoing a thorough 'landscape' patent search and discovering that CBDs were removed from the Schedule I list, designed a specific process that would not only extract CBDs, but also remove the Tetrahydrocannabinols (THC) from cannabis, which would result in a form enabling end users to receive the full efficacy of the CBDs without experiencing any of the psychoactive effects caused by THC. The THC-free cannabinoid material will be formulated into capsules, tablets, and topicals. CannaBank expects to release the first CBD-infused products into the marketplace over the next several months.
ABOUT MEDICAL MARIJUANA INC
Medical Marijuana Inc recognizes the vast and unequaled opportunities that exist in the rapidly expanding hemp and medical marijuana industries. The scientific recognition of cannabis has brought legalized marijuana use to the forefront of mainstream discussion, thus opening the door for safe and lucrative investment opportunities.
CannaBANK's mission is to help create a sustainable economy which in turn helps create a sustainable planet offering health and economic freedom through education and awareness.
CannaBank™ and the CannaBank™ logo are registered trademarks of Hemp Deposit & Distribution Corp. (HDDC), d/b/a CannaBANK, Inc. in the U.S. and certain other countries. All other trademarks mentioned in this document are the property of their respective owners. The use of the word "partner" does not imply a partner relationship between CannaBANK and any other company.
Since its inception, SkinAgain® has had one mission, to create healing products that provide the relief, beauty and wellness that people deserve using the powerful energies and pure elements that exist on our planet, while every day making this earth a better place to live by promoting environmentally friendly business practices and a positive, prosperous working environment.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.